1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
Exosome Diagnostics and Therapeutics: Global Markets

Exosome Diagnostics and Therapeutics: Global Markets

  • November 2021
  • 255 pages
  • ID: 5400250
  • Format: PDF
  • BCC Research

Summary

Table of Contents

Report Scope:
This report represents a current and important business tool to evaluate new commercial opportunities in the exosome diagnostic, therapeutic and research tool markets. The geographic scope of this study covers the U.S. and companies worldwide. This market is complex and consists of a number of different sectors, each affected differently by scientific and technological development. The report identifies the main positive and negative factors in each sector and forecasts further trends and product and assay development in every category of this industry.

Report Includes:
- 109 tables
- An updated review of the global market for exosome diagnostics and therapeutics within the biotech research industry
- Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Estimation and forecast the overall global market size, and corresponding market share analysis by application, end-user, and geographic region
- Description of immunological compatibility, cargo capabilities and other intrinsic therapeutic activities of exosomes
- Evaluation of exosome proteins and nucleic acids as diagnostic biomarkers and discussion of their impact on microRNA, liquid biopsy and stem cell research industry
- Information on bioinformatics databases for exosome research and product development, including as ExoCarta, Vesiclopedia and EVpedia
- Impact of exosome research on specific biopharmaceutical market and summary of details for major companies researching and producing exosome products
- A relevant patent analysis on Exosome Diagnostics and Therapeutics in the U.S., Europe and Japan
- Competitive landscape of the major players operating within global market, and their global rankings and company share analysis
- Profile descriptions of the leading vendor companies including Codiak BioSciences, Evox Therapeutics, Exosome Diagnostics Inc., NonoSomiX Inc., and System Biosciences,

Summary:
Initially, exosome particles were considered "garbage" molecules secreted by cells. Today, many researchers are convinced that these tiny vesicles have unlimited potential in diagnostics and therapeutics, especially in oncology treatments.

By definition, exosomes are small membrane sacs/vesicles, approximately 30 to 100 nanometers (nm) in diameter, that are released by both healthy and cancerous cells. Substances from cell cytoplasm-such as genomic DNA, various RNA species, proteins and lipids-are encapsulated into exosomes and shed into the extracellular environment.

Research shows that all fluids in the human body contain exosomes, which can transfer cytoplasmic ingredients to other cells either locally or at distant sites.Once they reach the recipient cells, cytoplasmic ingredients can alter their biology.

Thus, exosomes are being widely adopted by several end users, including hospitals, diagnostics centers and research institutions.

Scientists believe that various biomolecules in exosomes can be profiled and, consequently, may serve as useful biomarkers for different diseases.Nucleic acids such as RNA or DNA can be isolated from exosomes and further analyzed by various techniques.

This is now efficiently done with the use of software provided by key players. The software used in exosome therapeutic and diagnostic applications are used for extraction, isolation and other purposes.

Overall, the market for the exosome approach can be divided into two main segments: application and end user. The overall market is estimated to be worth $REDACTED million (see Summary Table below), with the potential to increase to $REDACTED million in the next five years with a compound annual growth rate (CAGR) of REDACTED%.

This report evaluates the diagnostic market affected by exosome research and the further potential of exosome-based tests and assays.Indeed, an exosome approach represents the opportunity to expand and develop the liquid biopsy market, a growing sector in cancer diagnostics.

Thus, increasing cancer prevalence worldwide generates huge opportunities for the liquid biopsy market. According to Our World in Data, about 42 million people worldwide had cancer in 2016, a more than two-fold increase from 1990.

This report also highlights developments in therapeutic and drug development sectors.There is a significant potential for using exosome depletion as a way of treating disease; cancer-generated exosomes can inhibit the immune response and stimulate angiogenesis, the development of new blood vessels.

Consequently, if these exosomes are removed, tumor growth might be inhibited, and anticancer agents can work more efficiently.

In addition, there is a potential for exosomes to be used as targeted delivery vehicles of therapeutic molecules to cancer cells-for example, delivering small interfering RNA-specific molecules (siRNA) for a particular oncogene expressed in a tumor cell. According to the U.S. National Library of Medicine, cell-based exosomes have a large number of roles and targets. Also, various studies have shown that exosomes have the potential to deliver various types of cargo to target cells efficiently.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

In-Vitro Fertilization Market Research Report by Instrument, by Technology, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • $ 3949
  • January 2022
  • 187 pages

In-Vitro Fertilization Market Research Report by Instrument (Cabinet, Incubators, and Micromanipulator), by Technology (Intra-cytoplasmic Sperm Injection and Preimplantation Genetic Diagnosis), by End ...

  • World
  • Diagnostics
  • Genetic Testing
  • Industry analysis

ref:plp2021

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on